The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to its Information Collection Request titled “Medication Therapy Management Improvements – Standardized Format (CMS-10396)” published on February 18, 2020.
The important role of pharmacists in providing front-line patient care has become even more pressing during the current pandemic. AMCP CEO Susan Cantrell, RPh, CAE writes about pharmacists' expanding role in the time of COVID-19.
Critical medications are in shortage due to COVID-19. In her latest blog post, AMCP CEO Susan A. Cantrell, RPh, CAE, discusses the prescription drug supply chain and highlights new COVID-19 resources for AMCP members.
The Academy of Managed Care Pharmacy (AMCP) thanks the Food and Drug Administration (FDA) for the opportunity to provide comments in response to the FDA/Federal Trade Commission (FTC) Workshop on a Competitive Marketplace for Biosimilars, held on March 9, 2020.
March 2020 Legislative & Regulatory Briefing: Articles include CMS Issues Contract Year 2021 and 2022 Medicare Advantage and Part D Proposed Rule; AMCP Shares CMS Resources for COVID-19 Response; AMCP Submits Comments on Drug Importation on Proposals
April 2020 AMCP News & Views: Read articles on AMCP Amicus Brief in Rutledge v. PCMA Warns Against a Ruling That Diminishes Use of Managed Care Pharmacy Tools; AMCP Launches Daily Dose: COVID-19 Weekly Edition; and more